BCRX FY 2011 Earnings — BioCryst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

BCRXBioCryst Pharmaceuticals, Inc.

$2B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M-69.1% YoY

Gross Profit

$20M100.0% margin

Operating Income

-$50M-252.4% margin

Net Income

-$57M-289.9% margin

EPS (Diluted)

$-1.26

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$32M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$82M

Total Liabilities

$67M

Stockholders' Equity

$15M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$64M	-69.1%
Gross Profit	$20M	$63M	-69.0%
Operating Income	-$50M	-$33M	-49.2%
Net Income	-$57M	-$33M	-74.0%